mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.04 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.04 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.04 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.04 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.04 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.04 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.04 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.04 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.04 |